279 related articles for article (PubMed ID: 25216770)
21. Combining machine learning and texture analysis to differentiate mediastinal lymph nodes in lung cancer patients.
Alves AFF; Souza SA; Ruiz RL; Reis TA; Ximenes AMG; Hasimoto EN; Lima RPS; Miranda JRA; Pina DR
Phys Eng Sci Med; 2021 Jun; 44(2):387-394. PubMed ID: 33730292
[TBL] [Abstract][Full Text] [Related]
22. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
Hegde P; Molina JC; Thivierge-Southidara M; Jain RV; Gowda A; Ferraro P; Liberman M
Semin Thorac Cardiovasc Surg; 2020; 32(1):162-168. PubMed ID: 31325576
[TBL] [Abstract][Full Text] [Related]
23. Optical differentiation between malignant and benign lymphadenopathy by grey scale texture analysis of endobronchial ultrasound convex probe images.
Nguyen P; Bashirzadeh F; Hundloe J; Salvado O; Dowson N; Ware R; Masters IB; Bhatt M; Kumar AR; Fielding D
Chest; 2012 Mar; 141(3):709-715. PubMed ID: 21885729
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
[TBL] [Abstract][Full Text] [Related]
25. Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.
Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
BMC Med Imaging; 2020 Feb; 20(1):12. PubMed ID: 32024469
[TBL] [Abstract][Full Text] [Related]
26. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S
Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.
Saydam O; Gokce M; Kilicgun A; Tanriverdi O
Med Oncol; 2012 Jun; 29(2):589-94. PubMed ID: 21380783
[TBL] [Abstract][Full Text] [Related]
28. Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration.
Fritscher-Ravens A; Bohuslavizki KH; Brandt L; Bobrowski C; Lund C; Knöfel WT; Pforte A
Chest; 2003 Feb; 123(2):442-51. PubMed ID: 12576364
[TBL] [Abstract][Full Text] [Related]
29. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
Lu P; Sun Y; Sun Y; Yu L
Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334
[TBL] [Abstract][Full Text] [Related]
30. Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer.
Wang Memoli JS; El-Bayoumi E; Pastis NJ; Tanner NT; Gomez M; Huggins JT; Onicescu G; Garrett-Mayer E; Armeson K; Taylor KK; Silvestri GA
Chest; 2011 Dec; 140(6):1550-1556. PubMed ID: 21636663
[TBL] [Abstract][Full Text] [Related]
31. The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.
Choi EK; Park HL; Yoo IR; Kim SJ; Kim YK
Eur Radiol; 2020 Jan; 30(1):442-451. PubMed ID: 31338654
[TBL] [Abstract][Full Text] [Related]
32. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
[TBL] [Abstract][Full Text] [Related]
33. Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast-enhanced and unenhanced CT.
Cascade PN; Gross BH; Kazerooni EA; Quint LE; Francis IR; Strawderman M; Korobkin M
AJR Am J Roentgenol; 1998 Apr; 170(4):927-31. PubMed ID: 9530036
[TBL] [Abstract][Full Text] [Related]
34. Differentiating benign from malignant mediastinal lymph nodes visible at EBUS using grey-scale textural analysis.
Edey AJ; Pollentine A; Doody C; Medford AR
Respirology; 2015 Apr; 20(3):453-8. PubMed ID: 25581536
[TBL] [Abstract][Full Text] [Related]
35. Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2007 May; 83(5):1826-9; discussion 1829-30. PubMed ID: 17462407
[TBL] [Abstract][Full Text] [Related]
36. Dual-energy computed tomography for evaluating nodal staging in lung adenocarcinoma: correlation with surgical pathology.
Huang HC; Huang YS; Chang YC; Shih JY; Chen JS; Chang YC; Wang TC
Jpn J Radiol; 2024 May; 42(5):468-475. PubMed ID: 38311704
[TBL] [Abstract][Full Text] [Related]
37. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
[TBL] [Abstract][Full Text] [Related]
38. New CT criteria for nodal staging in non-small cell lung cancer.
Kudo S; Imai K; Ishiyama K; Hashimoto M; Saito H; Motoyama S; Sato Y; Takashima S; Murata K; Minamiya Y
Clin Imaging; 2014; 38(4):448-453. PubMed ID: 24651060
[TBL] [Abstract][Full Text] [Related]
39. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
Mattes MD; Moshchinsky AB; Ahsanuddin S; Rizk NP; Foster A; Wu AJ; Ashamalla H; Weber WA; Rimner A
Clin Lung Cancer; 2015 Nov; 16(6):e253-8. PubMed ID: 26163919
[TBL] [Abstract][Full Text] [Related]
40. Ratio of lymph node to primary tumor SUVmax multiplied by maximal tumor diameter on positron emission tomography/integrated computed tomography may be a predictor of mediastinal lymph node malignancy in lung cancer.
Liu Y; Tang Y; Xue Z; Yang P; Ma K; Ma G; Chu X
Medicine (Baltimore); 2016 Nov; 95(46):e5457. PubMed ID: 27861398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
